Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Richard I. Steinhart currently holds 212 shares of BioXcel Therapeutics, Inc. (BTAI), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Richard I. Steinhart has been a net seller of BTAI stock. They have purchased $21.4K and sold $368.0K worth of shares.
Richard I. Steinhart's most recent insider trade was on Jun 15, 2026, when they sold 35 shares at $0.00 per share.
Richard I. Steinhart serves as Executive at BioXcel Therapeutics, Inc. (BTAI). They have executed 56 insider transactions totaling $389.4K over their tenure at the company.
Richard I. Steinhart holds the position of Executive at BioXcel Therapeutics, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 19 years and currently hold a stake valued at $0.
Richard I. Steinhart has shown a selling trading pattern, with $21.4K in total purchases and $368.0K in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Richard I. Steinhart was on Feb 1, 2021, when they sold $180.6K worth of BTAI shares. This transaction involved 3,750 shares at $48.15 per share.
Richard I. Steinhart currently owns 212 shares of BioXcel Therapeutics, Inc. (BTAI), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Richard I. Steinhart's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Richard I. Steinhart has 56 Form 4 filings on record as an insider at BioXcel Therapeutics, Inc..
Set alerts for Richard I. Steinhart and 40,000+ other insiders.